MARLBOROUGH, Mass., June 7, 2017 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that the Genius™ 3D Mammography™ exam is now the only mammogram that is FDA-approved as superior to ...

Hologic, Inc. HOLX recently announced the latest clinical evidence showing the effectiveness of its Genius AI-based ...

In 2009, Hologic revolutionized breast cancer screening with the introduction of the Genius™ 3D mammography™ exam, the only mammogram clinically proven and FDA approved as superior for all women, ...

Studies show new deep-learning algorithm helps radiologists detect breast cancers in their early stages when used with the Genius® 3D Mammography™ exam*1 The new technology represents a pivotal ...

Hologic has put forward more data bolstering the use of its artificial intelligence programs for detecting breast cancer through mammography. | Hologic put forward another study that bolsters the use ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), the world leader in breast cancer screening technology and the company behind the Genius™ 3D Mammography™ exam, applauds the U.S.

Hologic’s AI-Powered Mammography Technology “At Hologic, we are constantly pushing ourselves to innovate and enhance the ...

A study published in the American Journal of Roentgenology demonstrated the powerful potential of AI-powered mammography, ...

Hologic’s HOLX AI-powered mammography solutions are gaining clinical momentum. Amid ongoing radiologist shortages, the company’s 3DQuorum technology has shown potential to streamline radiologists’ ...

Hologic beats on revenue and earnings in latest quarter. Scientific study lends weight to the superiority of Hologic’s GENIUS 3D mammogram. Near-term headwinds like currency and slower international ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has approved 3DQuorum™ Imaging Technology, powered by Genius AI™.